Novogen - 4 Year Dividend History | KZIA

Historical dividend payout and yield for Novogen (KZIA) since 2015. The current TTM dividend payout for Novogen (KZIA) as of June 18, 2019 is $0.00. The current dividend yield for Novogen as of June 18, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.013B $0.000B
Kazia Therapeutics Limited is an oncology-focused biotechnology company. It develops anti-cancer drugs as well as provides pharmaceutical research and development technology solutions. The company's lead program is GDC-0084, a small molecule inhibitor of the PI3K / AKT / mTOR pathway, which is being developed to treat glioblastoma multiforme, the primary and most aggressive form of brain cancer. Kazia Therapeutics Limited, formerly known as Novogen Limited, is based in Sydney, Australia.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $108.806B 12.30
Gilead Sciences (GILD) United States $85.546B 10.39
Bio-Techne Corp (TECH) United States $7.848B 53.55